Mohd A. Rashid

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Reply to: Improving the Clinical Interpretability of Functional Drug Screens: A Suggestion for Standardized Clinical Decision Thresholds in Quadratic Phenotypic Optimization Platform.

Reply to: Improving the Clinical Interpretability of Functional Drug Screens: A Suggestion for Standardized Clinical Decision Thresholds in Quadratic Phenotypic Optimization Platform.

Journal: JCO precision oncology

Published: December 18, 2025

Functional combinatorial precision medicine for predicting and optimizing soft tissue sarcoma treatments.

Functional combinatorial precision medicine for predicting and optimizing soft tissue sarcoma treatments.

Journal: NPJ precision oncology

Published: August 20, 2024

A Combinatorial Functional Precision Medicine Platform for Rapid Therapeutic Response Prediction in AML.

A Combinatorial Functional Precision Medicine Platform for Rapid Therapeutic Response Prediction in AML.

Journal: Cancer medicine

Published: August 14, 2024

A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids.

A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids.

Journal: NPJ precision oncology

Published: November 16, 2023

Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancer.

Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancer.

Journal: Molecular oncology

Published: October 03, 2022

Splice-switch oligonucleotide-based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC-driven hepatocellular carcinoma.

Splice-switch oligonucleotide-based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC-driven hepatocellular carcinoma.

Journal: Bioengineering & translational medicine

Published: April 19, 2022

Artificial Intelligence Effecting a Paradigm Shift in Drug Development.

Artificial Intelligence Effecting a Paradigm Shift in Drug Development.

Journal: SLAS technology

Published: September 17, 2020

Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma.

Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma.

Journal: Experimental hematology & oncology

Published: January 12, 2020

Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.

Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.

Journal: Journal of hepatology

Published: April 01, 2019

Artificial Intelligence-Driven Designer Drug Combinations: From Drug Development to Personalized Medicine.

Artificial Intelligence-Driven Designer Drug Combinations: From Drug Development to Personalized Medicine.

Journal: SLAS technology

Published: September 26, 2018

Datasets describing the growth and molecular features of hepatocellular carcinoma patient-derived xenograft cells grown in a three-dimensional macroporous hydrogel.

Datasets describing the growth and molecular features of hepatocellular carcinoma patient-derived xenograft cells grown in a three-dimensional macroporous hydrogel.

Journal: Data in brief

Published: February 01, 2018

Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP).

Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP).

Journal: Science translational medicine

Published: March 03, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026